Aurum Biosciences
Aurum Biosciences is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series A.
About Aurum Biosciences
Aurum Biosciences is a startup founded in 2018 based in the United Kingdom. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences.
Aurum Biosciences is a clinical stage biopharmaceutical company focused on developing therapeutics and diagnostics for unmet clinical needs, primarily using oxygen carriers and proprietary MRI software. Its lead product, ABL-101, targets acute ischemic stroke and spinal cord injury, with potential applications in inflammation, oncology, and cardiovascular conditions.
Explore Aurum Biosciences's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.